Stocks · Health care · Pharmaceutical Preparations

ARROWHEAD PHARMACEUTICALS, INC.

ARWR Clue Score51
United States Fiscal year ends September CIK 0000879407 Results filed 4 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Hongbo Lu
12 May 2026
Director
Sold on a plan
2,970
$76.88
$228.33K
James C Hamilton
23 Apr 2026
Chief Medical Officer
Sold on a plan
10,000
$75.00
$750.00K
Daniel Joseph Apel
22 Apr 2026
Chief Financial Officer
Sold on a plan
8,730
$71.92
$627.86K
Daniel Joseph Apel
22 Apr 2026
Chief Financial Officer
Sold on a plan
1,157
$70.45
$81.51K
Daniel Joseph Apel
22 Apr 2026
Chief Financial Officer
Sold on a plan
3,208
$70.11
$224.91K
James C Hamilton
5 Mar 2026
Chief Medical Officer
Sold on a plan
10,000
$64.19
$641.90K
James C Hamilton
5 Jan 2026
Chief Medical Officer
Sold on a plan
309
$68.00
$21.01K
James C Hamilton
5 Jan 2026
Chief Medical Officer
Sold on a plan
437
$65.97
$28.83K
James C Hamilton
5 Jan 2026
Chief Medical Officer
Sold on a plan
1,200
$64.49
$77.39K
James C Hamilton
5 Jan 2026
Chief Medical Officer
Sold on a plan
12,711
$63.95
$812.87K
James C Hamilton
5 Jan 2026
Chief Medical Officer
Sold on a plan
14,792
$63.01
$932.04K
James C Hamilton
5 Jan 2026
Chief Medical Officer
Sold on a plan
6,090
$62.28
$379.29K
James C Hamilton
5 Jan 2026
Chief Medical Officer
Sold on a plan
4,625
$61.24
$283.24K
Patrick O'Brien
5 Jan 2026
COO
Sold on a plan
46
$68.00
$3.13K
Patrick O'Brien
5 Jan 2026
COO
Sold on a plan
2,336
$64.04
$149.60K
Patrick O'Brien
5 Jan 2026
COO
Sold on a plan
5,873
$62.91
$369.47K
Patrick O'Brien
5 Jan 2026
COO
Sold on a plan
900
$62.25
$56.03K
Patrick O'Brien
5 Jan 2026
COO
Sold on a plan
600
$61.12
$36.67K
Patrick O'Brien
5 Jan 2026
COO
Sold on a plan
313
$68.00
$21.28K
Patrick O'Brien
5 Jan 2026
COO
Sold on a plan
900
$66.01
$59.41K
Patrick O'Brien
5 Jan 2026
COO
Sold on a plan
2,700
$64.44
$173.99K
Patrick O'Brien
5 Jan 2026
COO
Sold on a plan
11,842
$63.84
$755.99K
Patrick O'Brien
5 Jan 2026
COO
Sold on a plan
13,451
$62.96
$846.87K
Patrick O'Brien
5 Jan 2026
COO
Sold on a plan
6,164
$62.23
$383.59K
Patrick O'Brien
5 Jan 2026
COO
Sold on a plan
4,368
$61.20
$267.32K
Christopher Richard Anzalone
2 Jan 2026
Chief Executive Officer
Sold on a plan
5,771
$66.39
$383.14K
Christopher Richard Anzalone
2 Jan 2026
Chief Executive Officer
Sold on a plan
7,416
$65.88
$488.57K
Mauro Ferrari
26 Dec 2025
Director
Sold on a plan
7,530
$70.00
$527.10K
Christopher Richard Anzalone
22 Dec 2025
Chief Executive Officer
Sold on a plan
2,574
$68.85
$177.22K
Christopher Richard Anzalone
22 Dec 2025
Chief Executive Officer
Sold on a plan
10,012
$68.33
$684.12K
Adeoye Y Olukotun
19 Dec 2025
Director
Sold on a plan
827
$68.48
$56.63K
Adeoye Y Olukotun
19 Dec 2025
Director
Sold on a plan
6,083
$68.04
$413.89K
Adeoye Y Olukotun
19 Dec 2025
Director
Sold on a plan
3,090
$66.70
$206.10K
Christopher Richard Anzalone
19 Dec 2025
Chief Executive Officer
Sold on a plan
1,319
$68.48
$90.33K
Christopher Richard Anzalone
19 Dec 2025
Chief Executive Officer
Sold on a plan
8,147
$68.01
$554.08K
Christopher Richard Anzalone
19 Dec 2025
Chief Executive Officer
Sold on a plan
3,979
$66.67
$265.28K
Victoria Vakiener
19 Dec 2025
Director
Sold on a plan
1,960
$68.39
$134.04K
Victoria Vakiener
19 Dec 2025
Director
Sold on a plan
5,281
$67.97
$358.95K
Victoria Vakiener
19 Dec 2025
Director
Sold on a plan
2,799
$66.63
$186.50K
William D. Waddill
19 Dec 2025
Director
Sold on a plan
500
$68.53
$34.27K
William D. Waddill
19 Dec 2025
Director
Sold on a plan
5,451
$68.01
$370.72K
William D. Waddill
19 Dec 2025
Director
Sold on a plan
2,416
$66.66
$161.05K

What was left out

Form 4 filings counted 30
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 42
Sales straight out of an exercise 2
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 528,641
History held since 15 Nov 2006